Medacta Announces FDA Clearance for Mecta-C Stand Alone Anterior Cervical Interbody Fusion Device
- 61
Media Release Medacta Announces FDA Clearance for Mecta-C Stand Alone Anterior Cervical Interbody Fusion Device CASTEL SAN PIETRO, 06 March 2020 - Medacta is proud to announce the clearance from the U.S. Food and Drug Administration (FDA) for the Mecta-C Stand Alone platform for anterior cervical discectomy and fusion procedures (ACDF). Mecta-C Stand Alone is indicated for use from C2 to T1 in skeletally mature patients suffering from degenerative disc disease. The platform incorporates the benefits of an anterior plate with a versatile screw system, thus requiring no additional fixation. The modular design is an important characteristic of the Mecta-C Stand Alone system, allowing the surgeon to intraoperatively select four plating options - Flush, Trio, Hybrid and Quattro - to best treat various patient needs and anatomies. Each option allows for either a locking screw or lag screw feature, and includes an easy-to-use locking mechanism that provides surgeons with unique intraoperative versatility. The Mecta-C Stand Alone anterior cervical interbody fusion devices are offered in TiPEEK, Medacta's plasma-sprayed titanium coating that provides an added value to improve stability and increase the migration resistance. Mecta-C Stand Alone is an indication-specific interbody fusion device which enriches the suite of 360° cervical solutions to provide a treatment to numerous cervical spine disorders. For more information on Medacta Spine visit spine.medacta.com. Contact Issuer: Medacta Group SA Key word(s): Health
End of Corporate News |
Language: | English |
Company: | Medacta Group SA |
Strada Regina | |
6874 Castel San Pietro | |
Switzerland | |
Phone: | +41 91 696 6060 |
E-mail: | [email protected], [email protected] |
Internet: | www.medacta.com |
ISIN: | CH0468525222 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 991689 |
End of News | EQS Group Media |
|
991689 06.03.2020
EQS Group is a leading international technology provider for Digital Investor Relations, Corporate Communications and Compliance. More than 8,000 companies worldwide trust EQS’s products and services to securely, efficiently, and simultaneously fulfil complex national and international disclosure and compliance requirements, and to reach stakeholders globally.